117 related articles for article (PubMed ID: 11809694)
1. Copper-64-pyruvaldehyde-bis(N(4)-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: monitoring therapy response with microPET and magnetic resonance imaging.
Lewis JS; Connett JM; Garbow JR; Buettner TL; Fujibayashi Y; Fleshman JW; Welch MJ
Cancer Res; 2002 Jan; 62(2):445-9. PubMed ID: 11809694
[TBL] [Abstract][Full Text] [Related]
2. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
[TBL] [Abstract][Full Text] [Related]
3. Production and tumour uptake of [64Cu]Pyruvaldehyde-bis (N4-methylthiosemicarbazone) for PET and/or therapeutic purposes.
Jalilian AR; Rowshanfarzad P; Kamrani YY; Shafaii K; Mirzaii M
Nucl Med Rev Cent East Eur; 2007; 10(1):6-11. PubMed ID: 17694494
[TBL] [Abstract][Full Text] [Related]
4. Excision of trocar sites reduces tumor implantation in an animal model.
Wu JS; Guo LW; Ruiz MB; Pfister SM; Connett JM; Fleshman JW
Dis Colon Rectum; 1998 Sep; 41(9):1107-11. PubMed ID: 9749493
[TBL] [Abstract][Full Text] [Related]
5. Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.
Lewis J; Laforest R; Buettner T; Song S; Fujibayashi Y; Connett J; Welch M
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1206-11. PubMed ID: 11158618
[TBL] [Abstract][Full Text] [Related]
6. Pneumoperitoneum does not influence trocar site implantation during tumor manipulation in a solid tumor model.
Halpin VJ; Underwood RA; Ye D; Cooper DH; Wright M; Hickerson SM; Connett WC; Connett JM; Fleshman JW
Surg Endosc; 2005 Dec; 19(12):1636-40. PubMed ID: 16211435
[TBL] [Abstract][Full Text] [Related]
7. Local treatment of abdominal wound reduces tumor implantation.
Wu JS; Pfister SM; Ruiz MB; Connett JM; Fleshman JW
J Surg Oncol; 1998 Sep; 69(1):9-13; discussion 14. PubMed ID: 9762885
[TBL] [Abstract][Full Text] [Related]
8. Impact of pneumoperitoneum on trocar site implantation of colon cancer in hamster model.
Jones DB; Guo LW; Reinhard MK; Soper NJ; Philpott GW; Connett J; Fleshman JW
Dis Colon Rectum; 1995 Nov; 38(11):1182-8. PubMed ID: 7587761
[TBL] [Abstract][Full Text] [Related]
9. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
Wallhaus TR; Lacy J; Whang J; Green MA; Nickles RJ; Stone CK
J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
[TBL] [Abstract][Full Text] [Related]
10. Abdominal incision tumor implantation following pneumoperitoneum laparoscopic procedure vs. standard open incision in a syngeneic rat model.
Paik PS; Misawa T; Chiang M; Towson J; Im S; Ortega A; Beart RW
Dis Colon Rectum; 1998 Apr; 41(4):419-22. PubMed ID: 9559624
[TBL] [Abstract][Full Text] [Related]
11. Retention of the radiotracers 64Cu-ATSM and 64Cu-PTSM in human and murine tumors is influenced by MDR1 protein expression.
Liu J; Hajibeigi A; Ren G; Lin M; Siyambalapitiyage W; Liu Z; Simpson E; Parkey RW; Sun X; Oz OK
J Nucl Med; 2009 Aug; 50(8):1332-9. PubMed ID: 19617332
[TBL] [Abstract][Full Text] [Related]
12. Investigation of copper-PTSM as a PET tracer for tumor blood flow.
Mathias CJ; Welch MJ; Perry DJ; McGuire AH; Zhu X; Connett JM; Green MA
Int J Rad Appl Instrum B; 1991; 18(7):807-11. PubMed ID: 1787092
[TBL] [Abstract][Full Text] [Related]
13. Implantation of colon cancer at trocar sites is increased by low pressure pneumoperitoneum.
Wu JS; Brasfield EB; Guo LW; Ruiz M; Connett JM; Philpott GW; Jones DB; Fleshman JW
Surgery; 1997 Jul; 122(1):1-7. PubMed ID: 9225907
[TBL] [Abstract][Full Text] [Related]
14. Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET.
Green MA; Klippenstein DL; Tennison JR
J Nucl Med; 1988 Sep; 29(9):1549-57. PubMed ID: 3261785
[TBL] [Abstract][Full Text] [Related]
15. Differential mechanism of retention of Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: a novel radiopharmaceutical for positron emission tomography imaging.
Fujibayashi Y; Taniuchi H; Wada K; Yonekura Y; Konishi J; Yokoyama A
Ann Nucl Med; 1995 Feb; 9(1):1-5. PubMed ID: 7779524
[TBL] [Abstract][Full Text] [Related]
16. Sodium hyaluronate carboxymethylcellulose-based bioresorbable membrane (Seprafilm)--does it affect tumor implantation at abdominal wound sites?
Underwood RA; Wu JS; Wright MP; Ruiz MB; Pfister SM; Connett JM; Fleshman JW
Dis Colon Rectum; 1999 May; 42(5):614-8; discussion 618-9. PubMed ID: 10344683
[TBL] [Abstract][Full Text] [Related]
17. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin.
Mathias CJ; Bergmann SR; Green MA
J Nucl Med; 1995 Aug; 36(8):1451-5. PubMed ID: 7629593
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of copper(II)-pyruvaldehyde bis (N-4-methylthiosemicarbazone) for tissue blood flow measurement using a trapped tracer model.
Young H; Carnochan P; Zweit J; Babich J; Cherry S; Ott R
Eur J Nucl Med; 1994 Apr; 21(4):336-41. PubMed ID: 8005157
[TBL] [Abstract][Full Text] [Related]
19. Maximum tolerated dose and large tumor radioimmunotherapy studies of 64Cu-labeled monoclonal antibody 1A3 in a colon cancer model.
Connett JM; Buettner TL; Anderson CJ
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3207s-3212s. PubMed ID: 10541365
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM.
Mathias CJ; Welch MJ; Raichle ME; Mintun MA; Lich LL; McGuire AH; Zinn KR; John EK; Green MA
J Nucl Med; 1990 Mar; 31(3):351-9. PubMed ID: 2308007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
